AssetMark Inc’s Amneal Pharmaceuticals AMRX Stock Holding History

AssetMark Inc’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$381	Hold	22	–	–	﹤0.01%	3336
2026 Q1	$273	Buy	+22	New	+$295	﹤0.01%	3284
2019 Q2	–	Sell	-1,495	Closed	-$21K	–	1332
2019 Q1	$21K	Sell	1,495 -37	-2%	-$489	﹤0.01%	872
2018 Q4	$21K	Sell	1,532 -312	-17%	-$5.62K	﹤0.01%	877
2018 Q3	$41K	Sell	1,844 -9	-0.5%	-$189	﹤0.01%	783
2018 Q2	$30K	Buy	+1,853	New	+$32.5K	﹤0.01%	828

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

AssetMark Inc's AMRX Position: Q2 2026 in Review

AssetMark Inc held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 22 shares worth $381. The position accounts for ﹤0.01% of the portfolio, ranked #3336.

AssetMark Inc first reported a position in AMRX in Q2 2018 and has held it in 6 quarters since. The position peaked at $41K in Q3 2018. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

AssetMark Inc held 22 shares of Amneal Pharmaceuticals worth $381 as of Q2 2026.
AssetMark Inc left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
Amneal Pharmaceuticals made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3336 holding.
AssetMark Inc first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 6 quarters since.
AssetMark Inc's Amneal Pharmaceuticals position peaked at $41K in Q3 2018.
310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.